Neurocrine Biosciences (NBIX) Misses Q1 EPS by 5c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $152.72 +1.26%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q1 EPS of $0.49, $0.05 worse than the analyst estimate of $0.54. Revenue for the quarter came in at $236.6 million versus the consensus estimate of $252.55 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- Neurocrine Bio. (NBIX) PT Lowered to $182 at Morgan Stanley
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
